Oct 13, 2017

EMERGO SUMMARY OF KEY POINTS:

  • Brazil’s ANVISA has published updated BGMP certification rules allowing for desktop reviews instead of on-site inspections.
  • The new BGMP requirements apply to Class III and IV device registrants able to provide adequate technical documentation for review.
  • A Normative Instruction from ANVISA is anticipated that will provide additional details on how the new BGMP certification process will work.

Brazil GMP inspection changes now official for medical device registrantsBrazilian medical device regulator ANVISA has published updated requirements allowing for quality management system certification for some higher-risk devices without on-site inspections.

As Emergo consultants in Brazil previously learned, ANVISA had proposed these changes to address a persistent Brazilian Good Manufacturing Practice (BGMP) inspection backlog. Proposed changes include implementing a risk-based quality system inspection regime, as well as start allowing “desktop reviews” of Class III and IV devices’ technical documentation in lieu of on-site facility inspections in order to certify BGMP compliance. Now, the regulator has published RDC 179/2017 (link in Portuguese) to bring these changes into force.

Three BGMP certification pathways

With the publication of RDC 179/2017, Brazilian market registrants now have three BGMP certification routes:

BGMP inspection changes now apply to all new and in-process inspection requests. A planned ANVISA  Normative Instruction guidance document should clarify specific documentation requirements and related issues.

Additional ANVISA and Brazilian GMP resources from Emergo:

  • ANVISA medical device registration consulting
  • BGMP implementation and compliance support
  • ANVISA medical device classification consulting
  • Whitepaper: Brazil’s medical device registration process
  • Whitepaper: BGMP requirements for medical device companies

Author

  • Stewart Eisenhart

Related

Brazilian Regulators Shaking Up BGMP Certification Process for Higher-risk Devices

EMERGO SUMMARY OF KEY POINTS:

  • Brazil’s ANVISA plans major changes to BGMP certification requirements for many higher-risk medical devices.
  • Class III and IV medical device registrants will undergo “desktop reviews” rather than onsite inspections for BGMP certification.
  • ANVISA will also implement a risk-based quality system inspection approach prioritizing higher-risk device manufacturers.
Read more

In Brief: US FDA, Brazil ANVISA Expand Lists of Qualified Audit Organizations for MDSAP

EMERGO SUMMARY OF KEY POINTS:

  • US and Brazilian medical device market regulators have updated their lists of organizations authorized to conduct QMS audits under the Medical Device Single Audit Program (MDSAP).
  • There are now four companies recognized as MDSAP auditing organizations and 13 organizations authorized by the US FDA to carry out audits.
  • Brazil’s ANVISA now recognizes nine MDSAP audit organizations.
Read more

Brazilian Regulators Propose Extending Validity Timeframes for Medical Devices

EMERGO SUMMARY OF KEY POINTS:

  • ANVISA intends to move medical device registration validity timeframes from five to 10 years.
  • Expanded validity timeframes should result in lower ongoing compliance costs for Brazilian market registrants.
  • The ANVISA proposal will undergo finalization following a 60-day comment period.
Read more

Have questions on what Emergo can do for you?

CONTACT US